These findings emphasize that although both indices reflect metabolic alterations, they capture different aspects of risk in PREGDM pregnancies: TyG as a marker of insulin resistance–related metabolic stress and AIP as an indicator of dyslipidemia-driven vascular dysfunction. The gene discussed is AIP; the disease is Insulin resistance.